n-3 polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers

Journal of Clinical Psychopharmacology

Volumn 26, Issue 6, 2006, Pages 661-665

  Buydens Branchey, Laure ^a   Branchey, Marc ^a  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID; PLACEBO; VEGETABLE OIL;

ADULT; ANXIETY; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COURSE EVALUATION; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; LOOSE FECES; MALE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SCORING SYSTEM; SUBSTANCE ABUSE; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PSYCHIATRIC STATUS RATING SCALES; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33751090450     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000246214.49271.f1     Document Type: Article

References (21)

1. Song C, Li X, Leonard BE, et al. Effects of dietary n-3 or n-6 fatty acids on interleukin-1beta-induced anxiety, stress, and inflammatory response in rats. J Lipid Res. 2003;44:1984-1991.
2. Song C, Leonard BE, Horrobin DF. Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced changes in behavior, corticosterone and immune response in rats. Stress. 2004;7:43-54.
3. Alessandri JM, Guesnet P, Vancassel S, et al. Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod Nutr Dev. 2004;44:509-538.
4. Young GS, Conquer J. Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev. 2005;45:1-28.
5. Yehuda S, Rabinovitz S, Mostofsky DI. Mixture of essential fatty acids lowers test anxiety. Nutr Neurosci. 2005;8:265-267.
6. Fux M, Benjamin J, Nemets B. A placebo-controlled cross-over trial of adjunctive EPA in OCD. J Psychiatr Res. 2004;38:323-325.
7. Hibbeln JR. Fish consumption and major depression. Lancet. 1998;351:1213.
8. Hibbeln JR, Salem N Jr. Omega-3 fatty acids and psychiatric disorders. Current status of the field. In: Mostofosky D, Yehuda S, Salem N Jr, eds. Fatty Acids: Physiological and Behavioral Functions. Totowa, NJ: Humana Press; 2001:311-330.
9. Merikangas KR, Metha RL, Molnar BE, et al. Comorbidity of substance use disorder with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict Behav. 1998;23:893-907.
10. McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9:199-213.
11. National Cancer Institute, US National Institutes of Health. Diet History Questionnaire. Available at: http://riskfactor.cancer.gov/DHQ/. Accessed 2005.
12. US Department of Agriculture, Agricultural Research Service. USDA National Nutrient Database for Standard Reference, Release 18. [Nutrient Data Laboratory Home Page]. Available at: http://www.nal.usda.gov/fnic/foodcomp. Accessed 2005.
13. McNair DM, Lorr M, Droppleman LF. Manual for the Profile of Mood States. San Diego, CA: Educational Testing Service; 1971.
14. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum; 1988.
15. International Society for the Study of Fatty Acids and Lipids. Recommendations for Dietary Intake of Polyunsaturated Fatty Acids in Healthy Adults. Brighton, UK: International Society for the Study of Fatty Acids and Lipids; 2004.
16. Buydens-Branchey L, Branchey M, McMakin DL, et al. Polyunsaturated fatty acid status and aggression in cocaine addicts. Drug Alcohol Depend. 2003;71:319-323.
17. Buydens-Branchey L, Branchey M, McMakin DL, et al. Polyunsaturated fatty acid status and relapse vulnerability in cocaine addicts. Psychiatry Res. 2003;120:29-35.
18. Maes M, Stevens WJ, Declerck LS, et al. Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression: further evidence for an inflammatory process during that illness. Prog Neuropsychopharmacol Biol Psychiatry. 1993;17:241-255.
19. Maes M, Bosmans E, Calabrese J, et al. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res. 1995;29:141-152.
20. Ma J, Folsom AR, Shshar E, et al. Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. Am J Clin Nutr. 1995;62:564-571.
21. Irribaren C, Markovitz JH, Jabobs DR Jr, et al. Dietary intake of n-3, n-6 fatty acids and fish: relationship with hostility in young adults - the CARDIA study. Eur J Clin Nutr. 2004;58:24-31.